Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.160
-0.020 (-0.92%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Aytu BioPharma Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Aytu BioPharma stock has a consensus rating of "Strong Buy" and an average price target of $9.50. The average 1-year stock price forecast is 339.81% higher than the current stock price, while the lowest is $7.00 (+224.07%) and the highest is $14.5 (+571.30%).
Price Target: $9.50 (+339.81%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 10, 2026.
Analyst Ratings
The average analyst rating for Aytu BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $14 → $15 | Buy | Maintains | $14 → $15 | +571.30% | Jun 10, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $7 | Buy | Reiterates | $7 | +224.07% | May 15, 2026 |
| Lake Street | Lake Street | Buy Maintains $7 | Buy | Maintains | $7 | +224.07% | May 14, 2026 |
Financial Forecast
Revenue This Year
53.75M
from 66.38M
Decreased by -19.03%
Revenue Next Year
70.63M
from 53.75M
Increased by 31.41%
EPS This Year
-1.14
from -0.11
EPS Next Year
-0.08
from -1.14
EPS and Forward PE are based on non-GAAP adjusted numbers.